4D Molecular Total Debt vs. Cash And Equivalents
| FDMT Stock | USD 7.79 0.20 2.50% |
For 4D Molecular profitability analysis, we use financial ratios and fundamental drivers that measure the ability of 4D Molecular to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well 4D Molecular Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between 4D Molecular's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of 4D Molecular Therapeutics over time as well as its relative position and ranking within its peers.
FDMT |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 4D Molecular. If investors know FDMT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 4D Molecular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.85) | Quarterly Revenue Growth (1.00) | Return On Assets (0.17) | Return On Equity (0.24) |
The market value of 4D Molecular Therapeutics is measured differently than its book value, which is the value of FDMT that is recorded on the company's balance sheet. Investors also form their own opinion of 4D Molecular's value that differs from its market value or its book value, called intrinsic value, which is 4D Molecular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 4D Molecular's market value can be influenced by many factors that don't directly affect 4D Molecular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 4D Molecular's value and its price as these two are different measures arrived at by different means. Investors typically determine if 4D Molecular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 4D Molecular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
4D Molecular Therapeutics Cash And Equivalents vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining 4D Molecular's current stock value. Our valuation model uses many indicators to compare 4D Molecular value to that of its competitors to determine the firm's financial worth. 4D Molecular Therapeutics is rated below average in total debt category among its peers. It is rated below average in cash and equivalents category among its peers creating about 16.43 of Cash And Equivalents per Total Debt. Comparative valuation analysis is a catch-all technique that is used if you cannot value 4D Molecular by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.FDMT Total Debt vs. Competition
4D Molecular Therapeutics is rated below average in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 810.17 Million. 4D Molecular claims roughly 14.67 Million in total debt contributing just under 2% to equities under Health Care industry.
FDMT Cash And Equivalents vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
4D Molecular |
| = | 14.67 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
4D Molecular |
| = | 241.09 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
FDMT Cash And Equivalents Comparison
4D Molecular is currently under evaluation in cash and equivalents category among its peers.
4D Molecular Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in 4D Molecular, profitability is also one of the essential criteria for including it into their portfolios because, without profit, 4D Molecular will eventually generate negative long term returns. The profitability progress is the general direction of 4D Molecular's change in net profit over the period of time. It can combine multiple indicators of 4D Molecular, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 16 K | 16.8 K | |
| Net Interest Income | 9.2 M | 9.6 M | |
| Interest Income | 9.2 M | 9.6 M | |
| Operating Income | -112.9 M | -107.2 M | |
| Net Loss | -95.9 M | -91.1 M | |
| Income Before Tax | -100.8 M | -95.8 M | |
| Total Other Income Expense Net | 12 M | 12.6 M | |
| Net Loss | -96.7 M | -91.9 M | |
| Net Loss | -100.8 M | -95.8 M | |
| Income Tax Expense | 5.6 M | 5.9 M | |
| Non Operating Income Net Other | 2.9 M | 3.1 M | |
| Change To Netincome | 19.7 M | 20.7 M | |
| Net Loss | (2.58) | (2.71) | |
| Income Quality | 0.75 | 0.58 | |
| Net Income Per E B T | 1.08 | 1.09 |
FDMT Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on 4D Molecular. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of 4D Molecular position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the 4D Molecular's important profitability drivers and their relationship over time.
Use 4D Molecular in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 4D Molecular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4D Molecular will appreciate offsetting losses from the drop in the long position's value.4D Molecular Pair Trading
4D Molecular Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to 4D Molecular could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 4D Molecular when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 4D Molecular - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 4D Molecular Therapeutics to buy it.
The correlation of 4D Molecular is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 4D Molecular moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 4D Molecular Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 4D Molecular can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your 4D Molecular position
In addition to having 4D Molecular in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Natural Foods Thematic Idea Now
Natural Foods
Companies producing natural foods including dairy products and different types of meets. The Natural Foods theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Natural Foods Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for FDMT Stock Analysis
When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.